神经肌肉疾病患者自主呼吸试验中的膈肌功能评估
本研究纳入机械通气超过7天、准备脱机的神经肌肉疾病患者,在多次T管试验中每30分钟用超声和NAVA导管测量膈肌功能直至成功脱机2小时。提示Edi和膈肌移动度变化可作为神经肌肉疾病患者脱机决策的附加客观工具。
要点
- 神经肌肉疾病患者脱机决策中,Edi下降和膈肌移动度增加与自主呼吸试验成功相关。
- 脱机时长每增加30分钟,Edi降低1.22 μV、膈肌移动度增加2.81 mm。
- 脱机每增加1天,Edi降低0.69 μV、膈肌移动度增加2.18 mm。
- Edi和膈肌移动度可作为脱机决策的附加客观工具,而非唯一依据。
适用人群与场景
- 神经肌肉疾病、机械通气超过7天、准备脱机的成人患者(原文未提及排除标准)。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 在多次T管试验期间,每30分钟使用超声测量膈肌移动度、使用NAVA导管测量Edi峰值,直至成功脱机2小时。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 成功呼吸试验由Edi下降(脱机时长每增加30分钟降1.22 μV;每增加1天降0.69 μV)和膈肌移动度增加(每30分钟增2.81 mm;每天增2.18 mm)预测。
证据类型、等级与局限
- 证据类型:小样本观察性研究(原文未明确设计类型),样本量8例,单中心(原文未明确),局限包括样本小、原文未提及盲法及验证。
对床旁实践的改变
- 在神经肌肉疾病患者脱机过程中,可每30分钟监测Edi和膈肌移动度,辅助判断自主呼吸试验是否成功;但样本小,不能替代临床综合评估。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The optimal time to discontinue patients from mechanical ventilation is critical as premature discontinuation as well as delayed weaning can result in complications. The literature on diaphragm function assessment during the weaning process in the intriguing subpopulation of critically ill neuromuscular disease patients is lacking.
METHODS: Patients with neuromuscular diseases, on mechanical ventilation for more than 7 days, and who were ready for weaning were studied. During multiple T-piece trials over days, diaphragm function using ultrasound and diaphragm electrical activity (Edi peaks using NAVA catheter) was measured every 30 min till a successful 2 h weaning.
RESULTS: A total of 18 patients were screened for eligibility over 5-month period and eight patients fulfilled the inclusion criteria. Sixty-three data points in these 8 subjects were available for analysis. A successful breathing trial was predicted by Edi reduction (1.22 μV for every 30 min increase in weaning duration; 0.69 μV for every day of weaning) and increase in diaphragm excursion (2.81 mm for every 30 min increase in weaning duration; 2.18 mm for every day of weaning).
CONCLUSION: The Edi and diaphragm excursion changes can be used as additional objective tools in the decision-making of the weaning trials in neuromuscular disease.
参考来源
- Krishnakumar M, Muthuchellappan R, Chakrabarti D, et al. Diaphragm Function Assessment During Spontaneous Breathing Trial in Patients with Neuromuscular Diseases. Neurocrit Care. 2020. PMID: 33210265. doi:10.1007/s12028-020-01141-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。